COUGH is the #9 most commonly reported adverse reaction for FLUTICASONE PROPIONATE, manufactured by Haleon US Holdings LLC. There are 4,087 FDA adverse event reports linking FLUTICASONE PROPIONATE to COUGH. This represents approximately 2.2% of all 187,924 adverse event reports for this drug.
Patients taking FLUTICASONE PROPIONATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH4,087 of 187,924 reports
COUGH is a less commonly reported adverse event for FLUTICASONE PROPIONATE, but still significant enough to appear in the safety profile.
Other Side Effects of FLUTICASONE PROPIONATE
In addition to cough, the following adverse reactions have been reported for FLUTICASONE PROPIONATE:
COUGH has been reported as an adverse event in 4,087 FDA reports for FLUTICASONE PROPIONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with FLUTICASONE PROPIONATE?
COUGH accounts for approximately 2.2% of all adverse event reports for FLUTICASONE PROPIONATE, making it a notable side effect.
What should I do if I experience COUGH while taking FLUTICASONE PROPIONATE?
If you experience cough while taking FLUTICASONE PROPIONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.